Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response
For several years, we have been committed to exploring the potential of Bordetella pertussis-derived outer membrane vesicles (OMVBp) as a promising third-generation vaccine against the reemerging pertussis disease. The results of our preclinical trials not only confirm its protective capacity agains...
Main Authors: | Bernarda Pschunder, Lucia Locati, Oriana López, Pablo Martin Aispuro, Eugenia Zurita, Matthew Stuible, Yves Durocher, Daniela Hozbor |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1387534/full |
Similar Items
-
A novel method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis Tohama strain
by: Mohammad Sekhavati, et al.
Published: (2020-03-01) -
Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life
by: Pablo Martin Aispuro, et al.
Published: (2020-04-01) -
Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture
by: Francisco Carriquiriborde, et al.
Published: (2021-09-01) -
A streamlined method for the extraction of outer membrane vesicles (OMVs) from Bordetella pertussis
by: M Sekhavati, et al.
Published: (2018-12-01) -
Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina
by: Francisco Carriquiriborde, et al.
Published: (2019-11-01)